VMD News
Viemed Healthcare, Inc.
$9.61
$0.00(0.00%)
66
Overall
80
Value
63
Tech
57
Quality
Market Cap
$365.65M
Volume
43.14K
52W Range
$6.05 - $12.61
Target Price
$12.50
VMD news: the latest Viemed Healthcare, Inc. headlines, press releases and market updates, newest first.
Latest VMD News
- Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Revolution Medicines (RVMD) and Viridian Therapeutics (VRDN)TipRanks Newsroom · Oct 14, 2026
- Revolution Medicines Draws $250 Million Term Loan FacilityTipRanks Auto-Generated Newsdesk · Oct 13, 2026
- Guggenheim Sticks to Its Buy Rating for Revolution Medicines (RVMD)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Analysts’ Top Healthcare Picks: Akari Therapeutics (AKTX), Corcept Therapeutics (CORT)TipRanks Newsroom · Oct 1, 2026
- Bernstein Sticks to Their Hold Rating for Revolution Medicines (RVMD)TipRanks Auto-Generated Intelligence Newsdesk · Sep 26, 2026
- Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead AssetNewswire TipRanks · Sep 25, 2026
- Revolution Medicines (RVMD) Gets a Buy from Goldman SachsTipRanks Auto-Generated Intelligence Newsdesk · Sep 24, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VMD | $9.61 | 0% | 43.14K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |